A groundbreaking study has revealed a simple yet effective solution for a common childhood sleep disorder. Imagine a natural remedy as powerful as steroids, but with fewer risks and side effects!
Researchers from Monash University and Melbourne Children's Sleep Centre have found that a prolonged course of intranasal saline can be just as effective as corticosteroids in treating obstructive sleep-disordered breathing (OSDB) in children. This discovery challenges the traditional approach to managing OSDB and opens up a new, low-risk avenue for primary care.
But here's where it gets controversial: the study suggests that intranasal saline, a simple nasal spray, could be a true first-line therapy, potentially reducing the need for specialist interventions and their associated risks and costs.
Lead author, Professor Gillian Nixon, a Pediatric Respiratory and Sleep Specialist, emphasizes the significance of these findings. She explains how the saline nasal sprays can significantly improve sleep quality for many children, often without the need for steroid sprays or surgery, which carry higher risks and longer recovery times.
"It's a common problem, and people often put up with it for a while. But with this low-risk option, we can make a real difference for many children," she says.
The study enrolled 150 children aged 3 to 12 years with symptoms consistent with OSDB, including habitual snoring. After an initial six-week course of intranasal saline, 29.5% of children experienced symptom resolution. Those who didn't respond were then randomized to either intranasal mometasone furoate (INS) or continued saline for another six weeks.
The results were eye-opening. Symptom resolution occurred in approximately 36% of both the INS and saline groups, with no clinically significant difference between the two. This means that even for initial non-responders, persisting with saline was just as effective as escalating to intranasal steroids.
And this is the part most people miss: no subgroup was identified where steroids provided added benefit. This challenges the long-held belief that corticosteroids are the logical next step after saline.
Secondary outcomes, including sleep quality, behavior, emotional functioning, and quality of life, showed no advantage for corticosteroids. Subgroup analyses found no evidence that age, tonsillar size, allergic rhinitis, weight, or baseline symptom severity influenced treatment response.
Safety-wise, the findings were reassuring. Adverse events were common but mostly mild and evenly distributed between groups. Nasal irritation and minor nosebleeds occurred at low rates, and all bleeding episodes were small and self-limiting. Corticosteroids did not reduce adverse nasal symptoms compared to saline.
Professor Nixon believes this treatment is a game-changer for many patients. "If we decide surgery is the right path, we can do so knowing we've explored all options and the child truly needs it," she says.
The implications for clinical practice are significant. OSDB affects up to 12% of children and is the leading indication for adenotonsillectomy, a surgical procedure. While surgery is effective, it carries costs, risks, and long waiting times. Current guidelines often prompt early referrals for polysomnography or surgical assessment, leading to delays in management.
The MIST+ data suggests a structured three-month trial of intranasal saline initiated in primary care could resolve symptoms in approximately half of children before they reach specialist services. This approach has the potential to reduce the burden of symptoms and unnecessary escalation of care.
The next step is to engage with primary care colleagues and discuss the findings and their potential impact on existing guidelines and treatment pathways. While current pathways do not include the use of saline nasal spray, Professor Nixon hopes these discussions will lead to a reevaluation of guidelines in the near future.
This study offers a fresh perspective on managing OSDB in children, highlighting the potential of a simple, low-risk intervention to make a significant impact on children's sleep and overall health.
